Insiders · MCRB

David S. Ege

Officer at Seres Therapeutics, Inc. (MCRB)

David S. Ege has filed 9 insider reports with the SEC since February 2022, as officer at Seres Therapeutics, Inc. (MCRB). David S. Ege made no open-market purchases or sales in the last 12 months. In the latest filing, on August 19, 2024, David S. Ege sold 1,128 shares of Seres Therapeutics, Inc. (MCRB) for $948 at an average of $0.84.

Filings
9
Companies
1
Bought on market
None
Sold on market
$89.1K

Companies where David S. Ege is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Seres Therapeutics, Inc. logo
MCRB
Seres Therapeutics, Inc.
Officer77,575$89.1K$1.24Aug 19, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David S. Ege with

Other insiders at the same companies

Questions about David S. Ege

What is David S. Ege's role at Seres Therapeutics, Inc.?
David S. Ege reports to the SEC as officer at Seres Therapeutics, Inc. (MCRB), according to the latest filing on August 19, 2024.
How many shares does David S. Ege own?
After the latest filing that states it, David S. Ege directly owned 77,575 shares of Seres Therapeutics, Inc. (MCRB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David S. Ege bought or sold stock recently?
The most recent open-market sale was on August 16, 2024: sold 1,128 shares of Seres Therapeutics, Inc. (MCRB) for $948 at an average of $0.84.
How do I get alerts when David S. Ege files?
Follow David S. Ege on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David S. Ege (SEC CIK 0001829360). Totals count each trade once, skipping amendments whose original is on file, from Feb 9, 2022 on. View on SEC EDGAR · Get this as JSON